| Ytd | -9.62% | |
| 1y | -94.18% |
| Open | 10.98 | Prev Close | 11.03 | Low | 9.87 | High | 10.98 | Mkt Cap | 167.51K |
| Vol | 191.21K | Avg Vol | 15.45K | EPS | -24.82 | P/E | -0.41 | Forward P/E | -2.45 |
| Beta | 1.09 | Short Ratio | 4.12 | Inst. Own | 29.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 10.57 | 200-d Avg | 13.50 | 1yr Est | 18.00 |
CEO Explains How Broad Patent Protection, Combined with First-Ever FDA IDE Approval, Positions enVVe
EnVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company") today
enVVeno Medical (NASDAQ:NVNO) reported quarterly losses of $(5.89) per share which missed the analys
First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal TrialClinical site activation and
Wednesday's session saw 269 companies set new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.